Background {#Sec1}
==========

Poor cerebral perfusion and fluctuations in cerebral oxygenation can adversely affect brain development \[[@CR1]--[@CR3]\]. Regional tissue oxygenation can be continuously monitored with near-infrared spectroscopy (NIRS). The use of this non-invasive technique in neonates allows for the deployment of interventions to stabilize or improve cerebral oxygenation and perfusion \[[@CR1], [@CR4]\]. Various NIRS-based measurement techniques, devices and sensors have been developed to monitor cerebral oxygenation. Most of the clinically used NIRS devices make use of continuous-wave (CW) light sources, which emit light with a constant intensity (Fig. [1](#Fig1){ref-type="fig"}a). CW-NIRS calculates the oxygen saturation from the measured absorption without the possibility of calculating the absolute oxygenated and deoxygenated haemoglobin concentrations. This technique has great value in monitoring the dynamics of cerebral tissue oxygenation but lacks in providing accurate absolute oxygenation estimates \[[@CR5]\]. Fig. 1Graphic representation of the emitted and detected light beam for the CW-NIRS and FD-NIRS techniques. The dark blue line represents the light entering the tissue; the light blue line represents the light that is detected at the detector. **a**, Intensity of emitted and detected light of the CW-NIRS technique. **b**, Intensity of the modulated light beam and measured parameters. Image adapted from OxiplexTS™ brochure with the courtesy of ISS, Champaign, Illinois, USA

Another NIRS technique, frequency-domain (FD) NIRS, allows for the determination of absolute values of haemoglobin concentration by modulating the intensity of the emitted light by a sinusoidal function. This results in amplitude of modulation (AC), average intensity (DC) and phase-shift (Fig. [1](#Fig1){ref-type="fig"}b) measurements, from which the absolute absorption and scattering coefficients are determined. The phase shift represents the delay between the emitted and detected waves of light and changes with the optical path length of the light through the tissue. From the absorption and scattering coefficients, absolute haemoglobin concentrations and subsequently regional cerebral oxygen saturation (rcSO~2~) are calculated. Measurements of absolute concentrations of haemoglobin may improve the interpretation of brain haemodynamics during various clinical settings and allow for within- and between-patient comparisons. While the CW-NIRS technique has been extensively evaluated in the clinical setting, including the transition after birth \[[@CR6]\], bedside FD-NIRS devices are not yet available, and the technique has yet to be evaluated properly in a clinical setting.

The aim of the present study was to compare the results of CW-NIRS and FD-NIRS monitoring devices in preterm neonates immediately after birth. If, in theory, both devices reflect true tissue oxygenation, we hypothesized that the cerebral oxygenation values measured with each device would be similar in absolute values as well as in trend during the transition after birth. As cerebral saturation gradually increases during the transition phase after birth, the measurement techniques can be compared over the full dynamic range of tissue oxygenation. In addition, data obtained with the FD-NIRS device might help us to understand the physiological changes that occur immediately after birth.

Methods {#Sec2}
=======

In this study, data from prospective observational studies performed at the Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands, and the Medical University of Graz, Graz, Austria, were compared. Those studies concerned neonates with a gestational age ≥ 30 weeks but \< 37 weeks, monitored during the first 15 min of life with an FD-NIRS device in Rotterdam, and with a CW-NIRS device in Graz.

FD-NIRS {#Sec3}
-------

FD-NIRS measurements were performed in newborn neonates between May 2015 and October 2017, delivered either vaginally or by caesarean section. Neonates with suspected congenital or chromosomal anomalies were excluded from the analyses. The local Medical Ethics Review Board waived approval (argument: "Medical Research in Human Subjects Act does not apply to this research proposal"; MEC-2011-415).

FD-NIRS measurements were performed using the OxiplexTS™ (ISS, Inc., Champaign, IL, USA) with the Infant Flexible Sensor, containing one detector and four emitter positions with two emitters each (eight in total). Emitter-detector distances on this device range from 1.5 cm to 4.0 cm. The device uses near-infrared light at two different wavelengths: 684 nm and 828 nm. Continuous FD-NIRS measurement data were collected over a maximum of 15 min, with a sampling rate of 0.5 s (2 Hz).

In addition to the preductal arterial oxygen saturation (SpO~2~) measurement used as standard of care, postductal SpO~2~ and heart rate (HR) were measured with pulse oximetry (Masimo Radical-7, Irvine, CA, USA). Any respiratory support was provided using a T-piece resuscitator (Neopuff, Fisher & Paykel Healthcare, Auckland, New Zealand).

CW-NIRS {#Sec4}
-------

For comparison, rcSO~2~ values obtained with a CW-NIRS device were provided by the Graz University Medical Centre. The data were obtained in prospective observational studies approved by the Regional Committee on Biomedical Research Ethics at the Medical University of Graz (EK- number: 19-291ex07/08, 23-403ex10/11, 27-465ex14/15). Written informed consent was obtained from the parents before the birth of the infant. All included neonates had been delivered by elective caesarean section. The CW-NIRS device used was the INVOS 5100C Cerebral/Somatic Oximeter (Medtronic, Minneapolis, MN, USA). Selected data have been published previously; methods and data acquisition are described in more detail in these publications \[[@CR7], [@CR8]\].

FD-NIRS data acquisition {#Sec5}
------------------------

A sensor calibration procedure was carried out before every measurement. The measurement time started when the umbilical cord was clamped, as this was clinical practice in both centres. Further, in both centres, as per the local protocol at the time the study was conducted, immediate cord clamping was the standard procedure and was performed before 30 s. The FD-NIRS sensor was placed on the baby's left frontotemporal forehead. A pulse oximeter was placed postductally on the baby's left foot. Upon signs of respiratory distress, supplemental oxygen and positive end-expiratory pressure (PEEP) therapy or ventilation were applied according to the local protocol. Physicians were blinded to the rcSO~2~ and SpO~2~ measurements. In contrast to the data acquisition method applied in Graz, where all neonates were monitored during the full first 15 min after birth, in Rotterdam, we were obligated by the Medical Ethics Review Board to stop the measurements once routine medical care had been completed and the baby was stable before the completion of the first 15 min after birth.

In addition to rcSO~2~, the FD-NIRS device provides absolute values of the total haemoglobin concentration (THb), oxygenated (O~2~Hb) and deoxygenated haemoglobin (HHb) concentration. To account for the displacement of the sensor, during postprocessing of the FD-NIRS data, measurements were discarded when the AC was below 1, the DC was below 10 or when values were considered non-physiological (values below 0 or above 100). Afterwards, the data were averaged over six seconds.

Phase shift {#Sec6}
-----------

To compare the CW-NIRS device and the FD-NIRS device, we evaluated the effect of the phase shift on the FD-NIRS measurement. Median (interquartile range; IQR) phase shifts are reported, and the effect of the change of phases over time for both wavelengths on rcSO~2~ was evaluated and presented for a single FD-NIRS measurement. All the phase-shift pairs that occurred during this measurement were used to recalculate a matrix of possible cerebral saturations. The percentiles of these recalculated cerebral saturations for all occurring phase-shift pairs were compared to the original raw cerebral saturation data.

Statistics {#Sec7}
----------

Categorical variables are presented as numbers (%); continuous variables are presented as medians (IQRs). Demographics were compared using Fisher's exact test for categorical data and the Mann-Whitney U test for continuous data. A per-minute analysis was performed for the rcSO~2~ values, comparing FD-NIRS and CW-NIRS data. The first minute was excluded from the analyses to account for sensor placement. For comparison between devices, data were stratified for the need for respiratory support \[[@CR7]\].

To adjust for the repeated rcSO~2~ measurements, we used mixed models to analyse the course of rcSO~2~, SpO~2~, THb, O~2~Hb, and HHb over time. The following fixed effects were considered in the model using backwards selection: the need for respiratory support, delivery method, gestational age, whether the neonate was small for gestational age (dichotomous) and sex. For the random effects, the use of random intercept and slopes were evaluated. To take into account non-linearity in the relation between time and rcSO~2~, SpO~2~, THb, O~2~Hb, and HHb, we explored the use of splines and quadratic terms for time. The final model used a mixed model with fixed effects for (non-linear) time, measurement technique (only for rcSO~2~ and SpO~2~) and respiratory support and a random intercept and slope as random effects. To account for non-linearity, a natural spline with 2 knots for time fit the data best in all mixed models. The results are presented as effect plots of the estimates and their 95% confidence intervals. A two-sided *P*-value of \< 0.05 was considered statistically significant. Statistical analyses were performed using the computing environment R (v3.4.1) \[[@CR9]\].

Results {#Sec8}
=======

Of 39 eligible neonates in Rotterdam, thirty-eight were included and measured with FD-NIRS. One neonate was diagnosed with ventriculomegaly and therefore excluded. Data from 58 neonates measured with CW-NIRS were available from the Medical University of Graz. Four neonates in Graz had been intubated and were therefore excluded. Table [1](#Tab1){ref-type="table"} summarizes demographic and clinical data. The groups significantly differed in gestational age and therefore in birthweight and head circumference. After adjustment for gestational age according to Fenton et al. \[[@CR10]\], the differences in birthweight and head circumference were not statistically significant. Thirty-four (59%) neonates from the CW-NIRS group and 25 (66%) from the FD-NIRS group needed respiratory support during the first 15 min after birth (*p* = 0.62). Table 1Demographics and clinical dataCW-NIRS (*n* = 58)FD-NIRS (*n* = 38)*P*-valueFemale sex30 (52%)14 (37%)0.22Gestational age (weeks)34 ^0^/~7~ \[32 ^4^/~7~--35 ^6^/~7~\]32 ^2^/~7~ \[31 ^4^/~7~--34 ^1^/~7~\]\< 0.01Birthweight (g)2066 \[1172--2366\]1763 \[1480--2011\]0.01Birthweight for age *SDS*^a^−0.3 \[− 1.0--0.2\]−0.2 \[− 0.8--0.6\]0.50Head circumference (cm)32.0 \[31.0--33.0\]29.5 \[28.0--31.8\]\< 0.01Head circumference for age *SDS*^b^0.0 \[0.0--1.0\]0.4 \[− 0.8--0.9\]0.91Arterial umbilical cord pH7.31 \[7.28--7.34\]7.29 \[7.26--7.34\]0.39Apgar Minute 18.5 \[8--9\]8 \[7--8\]0.02 Minute 59 \[8--10\]9 \[8--9\]0.12 Minute 1010 \[9--10\]9 \[9--10\]0.25Caesarean section58 (100%)27 (71%)\< 0.01Respiratory support34 (59%)25 (66%)0.62Reanimation^1^2 (3%)0 (0%)0.39SGA^2^7 (12%)7 (18%)0.57Values are median \[IQR\] or n (%); *SGA* Small for gestational age. ^a^ Birthweight-for-age SDS and ^b^Head circumference-for-age SDS were calculated according to Fenton et al. (ref) ^1^unknown in *n* = 1 from CW-NIRS group; ^2^ unknown in *n* = 1 from CW-NIRS group

Comparison {#Sec9}
----------

The effect plots of the estimated means stratified for the need for respiratory support are shown for both the CW-NIRS and FD-NIRS measurements (Fig. [2](#Fig2){ref-type="fig"}a and b). In the first 12 min, the rcSO~2~ values for the FD-NIRS device were consistently higher than those for the CW-NIRS device. After adjustment for respiratory support, the overall trend of rcSO~2~ over time differed significantly between the devices (*p* \< 0.01). Irrespective of the device used, the need for respiratory support significantly influenced cerebral oxygenation (*p* \< 0.01). Fig. 2Effect plots of rcSO~2~ and SpO~2~ stratified by the need for respiratory supportSymbols represent the estimated means of rcSO~2~ and SpO~2~ with associated 95% confidence intervals for all difference time points based on a mixed model including (non-linear) time, technique, respiratory support and their interaction with time. **a**, Effect plot of rcSO~2~ for neonates not requiring respiratory support. **b**, Effect plot of rcSO~2~ for neonates requiring respiratory support. **c**, Effect plot of SpO~2~ for neonates not requiring respiratory support. **d**, Effect plot of SpO~2~ for neonates requiring respiratory support.

Phase shift {#Sec10}
-----------

The raw cerebral saturation values of a single measurement are shown in dark blue in Fig. [3](#Fig3){ref-type="fig"}a, with percentiles of recalculated cerebral saturation values based on all occurring phase-shift pairs. Additionally, the raw phase-shift values for both wavelengths, 684 nm (light blue line) and 828 nm (dark blue line), are shown in Fig. [3](#Fig3){ref-type="fig"}b. The increase in the phase shift of the 828 nm wavelength results in the spread of the cerebral saturation centiles of approximately 20% saturation, and the changes of the phase over time result in a movement through the centiles (Fig. [3](#Fig3){ref-type="fig"}a). The visible drop in cerebral saturation is due to a small movement of the sensor during the measurement. The phase-shift values of the single measurement are comparable to the overall phase shift of the whole FD-NIRS group, 684 nm 6.23 \[6.04--6.43\], 828 nm 7.70 \[7.22--8.07\] and 684 nm 6.04 \[4.46--6.54\], 828 nm 7.20 \[5.66--7.81\], respectively. The median phase-shift values of all included FD-NIRS measurements are presented in supplementary Table [I](#MOESM1){ref-type="media"}. Fig. 3Effect of variance in phase-shift occurrences on cerebral saturation during a single frequency-domain measurement. **a,** Raw data of a single cerebral saturation measurement (dark blue line) and percentiles based on the recalculation of the cerebral saturation measurements based on all phase-shift pair occurrences (light blue ranges). **b,** Raw phase-shift values for 684 nm and 828 nm wavelengths

SpO~2~ {#Sec11}
------

Regarding the whole study population, the postductal SpO~2~ values increased during the transition period (Fig. [2](#Fig2){ref-type="fig"}c and d). The SpO~2~ values were significantly different between neonates with and without the need for respiratory support (*p* \< 0.01) and between the CW-NIRS and FD-NIRS groups (*p* \< 0.01). SpO~2~ values in the first four minutes after birth were predominantly lower in the FD-NIRS group.

Haemoglobin concentration {#Sec12}
-------------------------

The course of THb over the 15-min window did not significantly differ between neonates with and without respiratory support (*p* = 0.45); the same holds true for O~2~Hb (*p* = 0.20) and HHb (*p* = 0.10). The effect plots of the estimated means (Fig. [4](#Fig4){ref-type="fig"}) show a fairly constant THb value and a decrease over time for HHb. For O~2~Hb, an increase over time is seen in the respiratory support group, but such an increase is less evident in the non-respiratory support group. A significant time-dependent trend was seen for HHb values (*p* \< 0.01) but not for THb values (*p* = 0.45). The time-dependent trend of O~2~Hb did not reach statistical significance (*p* = 0.08). Fig. 4Effect plots of haemoglobin concentration measurements. **a**, Total haemoglobin concentration (THb); **b**, oxygenated haemoglobin concentration (O~2~Hb); and **c**, deoxygenated haemoglobin concentration (HHb). THb, O~2~Hb and HHb are presented as per μM. Symbols represent the estimated means with associated 95% confidence intervals for all difference time points, based on a mixed model including (non-linear) time, respiratory support and their interaction

Discussion {#Sec13}
==========

We compared the outcomes of two different measurement devices of cerebral oxygenation, INVOS 5100C (CW-NIRS) and OxiplexTS™ (FD-NIRS), during the immediate transition after birth in preterm neonates. After adjustment for the need for respiratory support, the time-dependent trend of the increase in cerebral oxygenation measured with the FD-NIRS device was significantly different from that measured with the CW-NIRS device. Not only the onset but also the slope differed over time. The need for respiratory support significantly influenced the course of the increase in cerebral saturation, irrespective of the device used.

From a technical perspective, the FD-NIRS device is superior. Clinically, we expect to see low cerebral saturation values at the beginning of the transition after birth. However, this is largely because most literature on cerebral saturation during the transition after birth is based on low saturation measurements with the INVOS. The lack of a gold-standard technique for the measurement cerebral saturation during this period makes it difficult to assess if these values are correct. From a medical point of view, we expect the SpO~2~ values to be higher than the measured rcSO~2~ values, which is not the case for the FD-NIRS group. This may indicate that FD-NIRS overestimates cerebral saturation.

The phase-shift values of 684 nm remain fairly constant throughout the single measurement, whereas the phase-shift values of 828 nm start at roughly the same point as 684 nm but increase over time. The magnitude of the change in the phase shift directly influences the spread between the centiles of the recalculated cerebral saturations in Fig. [3](#Fig3){ref-type="fig"}. Supplementary Table [I](#MOESM1){ref-type="media"} shows that the presented measurement is comparable to that of most other patients measured with FD-NIRS in this study. The changes in the phase shift over time are likely to improve the accuracy of an FD-NIRS device but limit the comparability between the FD-NIRS device and the CW-NIRS device. Without the knowledge of which physiological parameters are changing when and by how much, or of how they influence the phase measurement over time, and without more research into what other influences on the phase measurement exist, it is impossible to determine if phase-shift correction improves the cerebral saturation measurement. What is clear is that without it, the FD-NIRS measurements could change by as much as 20% rcSO~2~.

In both centres, immediate cord clamping was the standard of care. Although not significant, delayed cord clamping (DCC; \> 60 s) has been shown to be associated with lower rcSO~2~ immediately after cord clamping but with higher values when stabilized than immediate cord clamping \[[@CR11]\]. Additionally, a recent study concluded that DCC ≥ 30 s was associated with improved cerebral oxygenation in the first 24 h after birth \[[@CR12]\]. Although immediate cord clamping was the standard of care, an average delay in cord clamping in one of our centres or between infants with and without the need for respiratory support may have contributed to the differences found between devices. Medical professionals should be aware that DCC affects cerebral saturation immediately after birth and may lead to different onset of and increase in rcSO~2~.

Several studies comparing different devices, sensors and measurement techniques showed differences up to 14% between rcSO~2~ values \[[@CR13]--[@CR17]\]. One of these studies made use of stepwise induced hypoxia in healthy volunteers \[[@CR16]\]. In line with our findings, measurements of brain-derived parameters in that study significantly differed between FD-NIRS and CW-NIRS measurement techniques. FD-NIRS was not considered advantageous in parameter recovery \[[@CR16]\]. The within-subject reproducibility of cerebral oxygenation measurements can differ up to 10% \[[@CR14], [@CR17]--[@CR19]\]. Reproducibility, however, is of less importance for trend monitoring. To identify deviations from normal cerebral oxygenation, quantitative monitoring is key \[[@CR20]\]. Previous research using FD-NIRS to evaluate infants' brain development showed consistent results from repeated measurements \[[@CR21], [@CR22]\]. In 2007, the European Society for Paediatric Research proposed increasing the validity and comparability of peripheral NIRS measurements by standardizing the approach \[[@CR23]\]. This important initiative has to be extended to standardizing cerebral NIRS measurements, supported by the possibility of converting values from one oximeter to another. A first valuable attempt has been made using in vitro phantom testing \[[@CR24], [@CR25]\]. Furthermore, we recommend that the algorithms used by NIRS devices be published, as this enables us to investigate and understand where the differences in the readings come from.

The SpO~2~ values of neonates requiring respiratory support were slightly lower than those of neonates who did not require respiratory support. This finding may be due to inadequate lung aeration in neonates requiring respiratory support. Previous studies have reported both lower SpO~2~ and cerebral oxygen saturation values in neonates requiring respiratory support \[[@CR7], [@CR26]\]. In the present study, the trend in the postductally measured SpO~2~ values differed between the FD-NIRS and CW-NIRS groups, with predominantly lower values in the FD-NIRS group. Cerebral oxygenation is not solely determined by SpO~2~, but the higher rcSO~2~ values in the FD-NIRS group would likely have been even higher if the SpO~2~ would have been the same for both groups. The difference in SpO~2~ values between the groups makes proper comparison of the absolute differences between measured rcSO~2~ values nearly impossible.

The observed THb was stable over the 15-min monitoring period. As changes in arterial haemoglobin concentration are negligible, a clear decrease or increase in cerebral blood volume is not evident from these data, in contrast to the findings of Schwaberger et al. \[[@CR27]\]. For all three FD-NIRS parameters, there were no significant differences between neonates with and without the need for respiratory support. Although not significant, the expected increase over time for O~2~Hb occurred in the respiratory support group but not in the group of neonates who did not receive respiratory support, where even a slight decrease was seen. A possible explanation is the low number of measurements in the latter group, as infants were transferred to the resuscitation table after a few minutes with the parents, motion artefacts occurred and infants not needing respiratory support were more likely to return to the mother before 15 min as they were considered stable.

The CW-NIRS technique and the FD-NIRS technique each have shortcomings. By using a continuous light source, CW-NIRS assumes a degree of scattering. Due to the modulation of the emitted light, FD-NIRS allows for the quantification of the amount of light scatter, which theoretically results in more accurate measurements of tissue oxygenation. Moreover, FD-NIRS provides high-frequency raw data, resulting in a 'noisier' output. In addition, the device is equipped with a reusable but delicate and cumbersome neonatal sensor that easily results in motion artefacts due to movements of the infant and limits bedside usability and patient comfort. In addition, the OxiplexTS™ does not have a CE certificate for clinical use; therefore, it is available only for research purposes. For both devices, tissue homogeneity is assumed, which is debated in regard to the neonatal brain \[[@CR22], [@CR28]\]. In an inhomogeneous structure, the use of the mean pathlength by the FD-NIRS may overestimate or underestimate the absolute values of oxygenation.

Several limitations of this study need to be addressed. First, this study compared two devices incorporating different measurement techniques. The observed differences in this study may not be solely attributable to differences between FD-NIRS and CW-NIRS. The differences may result from differences between devices (e.g., different algorithms and emitter-detector differences), as discrepancies between devices using the same measurement technique are reported \[[@CR13]--[@CR15], [@CR24], [@CR25]\]. As this study was a comparison between two specific NIRS devices, the results may not be representative of the whole spectrum of available CW-NIRS and FD-NIRS devices.

Second, FD-NIRS measurement data from our centre were compared with CW-NIRS data from the centre in Graz \[[@CR8], [@CR29]\]. Although individual patient data were used, allowing for repeated measurement comparisons using mixed models, a randomized controlled trial would have been preferable. Third, while all included children in Graz were born by caesarean section, the included children in our centre were born either by vaginal delivery or by caesarean section. Nevertheless, previous research showed no differences in rcSO~2~ with respect to the mode of delivery, nor did our data \[[@CR30]\]. Fourth, although not of significant influence on our model, the difference in gestational age between the FD-NIRS and CW-NIRS groups may have caused differences in measured rcSO~2~ and SpO~2~ values and may have affected the need for respiratory support. Fifth, the SpO~2~ was measured postductally, as preductal measurements could not be recorded without interfering with routine medical care in the FD-NIRS patients. As postductal SpO~2~ values tend to be lower than preductal SpO~2~ values, fractional tissue oxygen extraction values were not calculated.

Conclusion {#Sec14}
==========

This research demonstrated that rcSO~2~ values and trends over time differed between devices, mostly in the first minutes after birth. It remains challenging to compare results from different devices, as not only the specific technique but also the specific algorithms and emitter-detector distances may have had a large impact on the outcomes. The FD-NIRS technique might be technically superior to the CW-NIRS technique, but from a clinical point of view, the FD-NIRS technique seems to overestimate true cerebral oxygenation. To date, in the neonatal transition period, the technical superiority of FD-NIRS devices does not outweigh the usability of the more clinically viable and widely used CW-NIRS devices. Additional haemoglobin concentration measurements may, in a research setting, provide more information on changes in cerebral haemodynamics. The absolute differences found may not be relevant in clinical practice, as trend monitoring of rcSO~2~ in combination with SpO~2~ may suffice to guide support during the transition.
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AC

:   Amplitude of modulation

CW

:   Continuous-wave

DC

:   Average intensity

FD

:   Frequency-domain

HHb

:   Deoxygenated haemoglobin concentration

HR

:   Heart rate

NIRS

:   Near-infrared spectroscopy

O~2~Hb

:   Oxygenated haemoglobin concentration

PEEP

:   Positive end-expiratory pressure

rcSO~2~

:   Regional cerebral oxygen saturation

SpO~2~

:   Arterial oxygen saturation

THb

:   Total haemoglobin concentration
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